Nanobac Pharmaceuticals, Incorporated (NNBP)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2007 2006 2005 2004 2003 2002
Revenue 17.62 Thousand 225.08 Thousand 656.8 Thousand 358.36 Thousand 482.81 Thousand 11.55 Thousand
Cost of Revenue 14.51 Thousand 79.8 Thousand 229.44 Thousand 100.47 Thousand 333.12 Thousand 4316.00
Gross Profit 3102.00 145.28 Thousand 427.35 Thousand 257.89 Thousand 149.69 Thousand 7239.00
Operating Expenses 4.91 Million 4.95 Million 3.26 Million 7.85 Million 2.84 Million 1.48 Million
Selling, General and Administrative Expenses 3.3 Million 1.83 Million 1.31 Million 4.76 Million 2.12 Million 26.87 Thousand
Research and Development Expenses 1.14 Million 1.99 Million 1.19 Million 2.37 Million 540.42 Thousand -
Other Expenses - - - - - -
Cost and Expenses 4.93 Million 5.03 Million 3.49 Million 7.95 Million 3.18 Million 1.48 Million
Operating Income 4.91 Million 4.81 Million 2.83 Million 7.6 Million 2.7 Million 1.47 Million
Interest Expense - - - - - -
Income Tax Expense 1.66 Million 158.81 Thousand 849.64 Thousand 274.39 Thousand 999.28 Thousand -
Earnings before Tax -6.57 Million -4.97 Million -3.68 Million -7.81 Million -2.76 Million -1.47 Million
Net Income -6.57 Million -4.97 Million -3.68 Million -7.87 Million -3.69 Million -1.47 Million
Earnings Per Share Basic - -0.02 -0.02 -0.05 -0.05 -0.07
Earnings Per Share Diluted - -0.02 -0.02 -0.05 -0.05 -0.04
Weighted Average Shares Outstanding - 199.42 Million 188.85 Million 152.9 Million 67.48 Million 19.98 Million
Weighted Average Shares Outstanding (Diluted) - 199.42 Million 188.85 Million 152.9 Million 67.48 Million 36.25 Million
Gross Margin 0.18 0.65 0.65 0.72 0.31 0.63
EBIT Margin -169.12 -16.56 -1.98 -19.29 -5.17 -127.68
Profit Margin -373.20 -22.10 -5.61 -21.97 -7.66 -127.68
EBITDA -5.92 Million -4.23 Million -2.85 Million -6.88 Million -2.51 Million -1.47 Million
Earnings Before Tax Margin 278.92 21.39 4.32 21.21 5.59 127.68

Income Statement Charts